Meeder Asset Management Inc Innoviva, Inc. Transaction History

Meeder Asset Management Inc

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $952 - $1,248	82 Added 205.0%	122 $1,000
Q2 2022 Aug 08, 2022	BUY	$14.32 - $19.88 $114 - $159	8 Added 25.0%	40 $1,000
Q1 2022 May 10, 2022	BUY	$15.39 - $20.25 $492 - $648	32 New	32 $1,000
Q4 2021 Feb 11, 2022	SELL	$15.91 - $18.72 $556 - $655	-35 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$13.06 - $17.24 $143 - $189	11 Added 45.83%	35 $1,000
Q2 2021 Aug 09, 2021	SELL	$11.45 - $13.96 $755 - $921	-66 Reduced 73.33%	24 $0
Q4 2020 Feb 09, 2021	SELL	$9.33 - $12.48 $522 - $698	-56 Reduced 38.36%	90 $1,000
Q3 2020 Nov 02, 2020	BUY	$10.33 - $14.49 $1,260 - $1,767	122 Added 508.33%	146 $2,000
Q2 2020 Aug 11, 2020	BUY	$11.49 - $15.26 $275 - $366	24 New	24 $0
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $738 - $1,385	-91 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$10.28 - $14.38 $935 - $1,308	91 New	91 $1,000
Q2 2019 Aug 05, 2019	SELL	$13.1 - $14.95 $149,981 - $171,162	-11,449 Closed	0 $0
Q1 2019 Apr 16, 2019	BUY	$13.69 - $20.06 $156,736 - $229,666	11,449 New	11,449 $160,000
Q4 2018 Jan 17, 2019	SELL	$13.96 - $18.26 $3,434 - $4,491	-246 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$13.63 - $15.7 $30,354 - $34,963	-2,227 Reduced 90.05%	246 $0
Q2 2018 Jul 24, 2018	BUY	$13.44 - $17.59 $1,962 - $2,568	146 Added 6.27%	2,473 $0
Q1 2018 May 03, 2018	BUY	$13.8 - $16.99 $24,495 - $30,157	1,775 Added 321.56%	2,327 $39,000
Q4 2017 Feb 02, 2018	BUY	$11.73 - $14.75 $1,618 - $2,035	138 Added 33.33%	552 $8,000
Q3 2017 Oct 20, 2017	BUY	$12.06 - $14.12 $4,992 - $5,845	414	414 $6,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.